3-(5-Methylthiophen-2-yl)-1H-pyrazole-5-carboxylic acid, 95.0%, 5g

4-Bromo-2-chloro-6-methoxypyridine, 95.0%, 250mg

Cubetas de electroporación 450 µl 50 uds.

5-Bromo-4-methoxy-1-methylpyridin-2(1H)-one, 98%, 100mg

2-[(2-methylbenzyl)thio]ethanamine, 95.0%, 100mg

N2-Fmoc-D-lysine Hydrochloride, 98.0%, 5g

2,2-Dimethyl-4-oxo-3,8,11,14,17-pentaoxa-5-azanonadecan-19-oic acid, 98%, 5g

5-Amino-2-bromopyrimidine, 95.0%, 25g

BENZYL ((5-METHYLPIPERIDIN-2-YL)METHYL)CARBAMATE HCL, 95.0%, 250mg

Solución de hematoxilina según. a Gill II, 1 l, vidrio

2,3-Dichlorophenylacetic acid, 98.0%, 100g

(2-Isopropylthiazol-4-yl)methanamine dihydrochloride, 95.0%, 100mg

3-[3-(4-Chlorophenyl)ureido]-4-ethoxybenzenesulfonyl chloride, 1g